KR101519673B1 - 피레녹신을 함유하는 현탁형 수성 액제 - Google Patents
피레녹신을 함유하는 현탁형 수성 액제 Download PDFInfo
- Publication number
- KR101519673B1 KR101519673B1 KR1020097018762A KR20097018762A KR101519673B1 KR 101519673 B1 KR101519673 B1 KR 101519673B1 KR 1020097018762 A KR1020097018762 A KR 1020097018762A KR 20097018762 A KR20097018762 A KR 20097018762A KR 101519673 B1 KR101519673 B1 KR 101519673B1
- Authority
- KR
- South Korea
- Prior art keywords
- container
- pyrinoxine
- castor oil
- aqueous solution
- trometamol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- C07D489/04—Salts; Organic complexes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007063787 | 2007-03-13 | ||
JPJP-P-2007-063787 | 2007-03-13 | ||
PCT/JP2008/054566 WO2008111630A1 (ja) | 2007-03-13 | 2008-03-13 | ピレノキシンを含有する懸濁型水性液剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090118960A KR20090118960A (ko) | 2009-11-18 |
KR101519673B1 true KR101519673B1 (ko) | 2015-05-12 |
Family
ID=39759561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097018762A KR101519673B1 (ko) | 2007-03-13 | 2008-03-13 | 피레녹신을 함유하는 현탁형 수성 액제 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP4958818B2 (ja) |
KR (1) | KR101519673B1 (ja) |
CN (2) | CN102716079B (ja) |
TW (1) | TWI465236B (ja) |
WO (1) | WO2008111630A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2269575A1 (en) | 2009-06-30 | 2011-01-05 | Santen Pharmaceutical Co., Ltd | Method for improving bioavailability of latanoprost |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070021507A1 (en) * | 2004-11-05 | 2007-01-25 | Shirou Sawa | Aqueous eye drops with accelerated intraocular migration |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3612537C1 (de) * | 1986-04-14 | 1987-07-16 | Dispersa Ag | Arzneimittel zur Behandlung von Entzuendungen im Auge |
DE3612538A1 (de) * | 1986-04-14 | 1987-10-15 | Dispersa Ag | Stabilisierung von quecksilberhaltigen konservierungsmitteln in augentropfen |
JPH0737386B2 (ja) * | 1988-10-12 | 1995-04-26 | 参天製薬株式会社 | 懸濁型ピレノキシン点眼剤 |
JPH0676319B2 (ja) * | 1988-12-20 | 1994-09-28 | 大正製薬株式会社 | トコフェロール類含有液剤 |
JPH04300830A (ja) * | 1991-03-28 | 1992-10-23 | Zeria Pharmaceut Co Ltd | ビタミンe類の水溶液の製剤 |
CN1101677C (zh) * | 1997-05-30 | 2003-02-19 | 韩万愚 | 含有紫杉醇的药用注射溶液 |
WO2000059470A1 (fr) * | 1999-04-05 | 2000-10-12 | Senju Pharmaceutical Co., Ltd. | Emulsion et son procede de production |
JP4748289B2 (ja) * | 2000-06-23 | 2011-08-17 | ライオン株式会社 | 点眼剤、眼科用組成物及び吸着抑制方法 |
JP3876355B2 (ja) * | 2000-09-13 | 2007-01-31 | 参天製薬株式会社 | 点眼液 |
JP2005154437A (ja) * | 2003-11-07 | 2005-06-16 | Rohto Pharmaceut Co Ltd | トラニラスト含有医薬組成物 |
CN100362991C (zh) * | 2004-06-02 | 2008-01-23 | 刘继东 | 一种眼科用药物组合物 |
WO2006030851A1 (ja) * | 2004-09-15 | 2006-03-23 | Santen Pharmaceutical Co., Ltd. | ピレノキシン懸濁型点眼剤 |
JP2006111621A (ja) * | 2004-09-15 | 2006-04-27 | Santen Pharmaceut Co Ltd | ピレノキシン懸濁型点眼剤 |
JP2007008928A (ja) * | 2005-06-01 | 2007-01-18 | Rohto Pharmaceut Co Ltd | アシタザノラスト含有水性組成物 |
JP2007119422A (ja) * | 2005-10-31 | 2007-05-17 | Santen Pharmaceut Co Ltd | 合成樹脂成形物に吸着しやすい薬物の吸着抑制方法 |
-
2008
- 2008-03-10 TW TW097108277A patent/TWI465236B/zh active
- 2008-03-13 CN CN201210199322.4A patent/CN102716079B/zh not_active Expired - Fee Related
- 2008-03-13 WO PCT/JP2008/054566 patent/WO2008111630A1/ja active Application Filing
- 2008-03-13 CN CN200880007992.3A patent/CN101636163B/zh active Active
- 2008-03-13 JP JP2008063416A patent/JP4958818B2/ja active Active
- 2008-03-13 KR KR1020097018762A patent/KR101519673B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070021507A1 (en) * | 2004-11-05 | 2007-01-25 | Shirou Sawa | Aqueous eye drops with accelerated intraocular migration |
Also Published As
Publication number | Publication date |
---|---|
CN101636163B (zh) | 2015-07-08 |
TWI465236B (zh) | 2014-12-21 |
JP4958818B2 (ja) | 2012-06-20 |
WO2008111630A1 (ja) | 2008-09-18 |
JP2008255111A (ja) | 2008-10-23 |
CN101636163A (zh) | 2010-01-27 |
CN102716079A (zh) | 2012-10-10 |
KR20090118960A (ko) | 2009-11-18 |
TW200906415A (en) | 2009-02-16 |
CN102716079B (zh) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI91217C (fi) | Farmaseuttisen tai diagnostisen aineen oftalmologinen kantoainekoostumus | |
EP3096745B1 (en) | Transdermal delivery system comprising donepezil or its salt | |
EP2506878A2 (en) | Process for preparing pharmaceutical ophthalmic compositions | |
JPH01299230A (ja) | ピロキシカムの医薬組成物水溶液およびその製造方法 | |
KR20170056702A (ko) | 지효성 약제학적 조성물 | |
US20240016732A1 (en) | Oral composition of celecoxib for treatment of pain | |
KR101475965B1 (ko) | 플루오로메토론을 함유하는 현탁형 점안제 | |
EP2571488B2 (en) | Pharmaceutical composition of ibuprofen for injection | |
EP3370697B1 (en) | Physically and chemically stable oral suspensions of givinostat | |
EP4138841B1 (en) | A formulation for treating ophthalmic conditions | |
KR101519673B1 (ko) | 피레녹신을 함유하는 현탁형 수성 액제 | |
US10463674B2 (en) | Process for manufacturing sterile ophthalmic pharmaceutical suspensions | |
WO2010119942A1 (ja) | レボカバスチン懸濁型点眼剤 | |
AU2022347454A1 (en) | Ophthalmic pharmaceutical compositions of roflumilast | |
CN108136036A (zh) | 包含瑞巴派特的新型眼科组合物及其制备方法 | |
JP2006111621A (ja) | ピレノキシン懸濁型点眼剤 | |
EP4316485A1 (en) | Suspension containing heterocyclidene acetamide derivative | |
Patel et al. | Design and characterization of ofloxacin mucoadhesive in situ hydrogel | |
EP4082544A1 (en) | Aqueous suspension composition containing sirolimus or salt thereof | |
WO2022195382A1 (en) | A stable ophthalmic nanosupension of brinzolamide | |
AU2023214622A1 (en) | Multidose ophthalmic compositions | |
WO2022096702A1 (en) | Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof | |
CN116139249A (zh) | 一种环孢素混悬滴眼液及其制备方法 | |
EP3965732A1 (en) | Pharmaceutical compositions for treating presbyopia and methods for fabricating thereof | |
CN117442615A (zh) | 一种h2受体拮抗剂药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20180417 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190417 Year of fee payment: 5 |